Evidence map›Paper›PMID 21666056›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2011

Physical and functional bivalency observed among TCR/CD3 complexes isolated from primary T cells.

Adam G Schrum, Diana Gil, Laurence A Turka, Ed Palmer

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Molecular architecture of the αβ T cell receptor-CD3 complex.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  4. Article
  5. Toward T cell protein-protein interaction activity relevant to alopecia areata.The journal of investigative dermatology. Symposium proceedings · 2013
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 3 countries.

Adam G SchrumDepartment of Immunology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. Schrum.Adam@mayo.edu
Diana Gil
Laurence A Turka
Ed Palmer
Mayo Clinic · USUniversidad Complutense de Madrid · ESUniversity Hospital of Basel · CHUniversity of Pennsylvania · US

Funding

T Cell Fate as a Determinant of Alloimmune ResponsesP01AI041521 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI TURKA, LAURENCE A · 1997 to 2011
$15.9M
SINGLE CELL ANALYSIS OF T CELL RESPONSES TO ANTIGENP01AI043620 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI CHOI, YONGWON · 1998 to 2010
$10.7M
Role of TCR-dependent AICD in tumor immunityF32CA103374 · NCI · UNIVERSITY HOSPITAL BASEL · PI SCHRUM, ADAM G. · 2003 to 2006
$141k
NCI NIH HHS F32 CA103374NIAID NIH HHS AI41521NIAID NIH HHS AI43620NIAID NIH HHS P01 AI041521NIAID NIH HHS P01 AI043620
6 · The paper itself

Abstract

Unlike BCR and secreted Ig, TCR expression is not thought to occur in a bivalent form. The conventional monovalent model of TCR/CD3 is supported by published studies of complexes solubilized in the detergent digitonin, in which bivalency was not observed. We revisited the issue of TCR valency by examining complexes isolated from primary αβ T cells after solubilization in digitonin. Using immunoprecipitation followed by flow cytometry, we unexpectedly observed TCR/CD3 complexes that contained two TCRs per complex. Standard anti-TCR Abs, being bivalent themselves, tended to bind with double occupancy to bivalent TCRs; this property masked the presence of the second TCR per complex in certain Ab binding assays, which may partially explain why previous data did not reveal these bivalent complexes. We also found that the prevalence of bivalency among fully assembled, mature TCR/CD3 complexes was sufficient to impact the functional performance of immunoprecipitated TCRs in binding antigenic peptide/MHC-Ig fusion proteins. Both TCR positions per bivalent complex required an Ag-specific TCR to effect optimal binding to these soluble ligands. Therefore, we conclude that in primary T cells, TCR/CD3 complexes can be found that are physically and functionally bivalent. The expression of bivalent TCR/CD3 complexes has implications regarding potential mechanisms by which Ag may trigger signaling. It also suggests the possibility that the potential for bivalent expression could represent a general feature of Ag receptors.

Indexed as

Adaptive ImmunityAnimalsCD3 ComplexFlow CytometryImmunoprecipitationMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutMice, TransgenicProtein MultimerizationReceptor-CD3 Complex, Antigen, T-CellT-Lymphocyte SubsetsCD3 ComplexReceptor-CD3 Complex, Antigen, T-Cell

Identifiers

PMID21666056
PMCPMC3131427
OpenAlexW1701698303

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.